Charles River Laboratories Long Term Debt 2010-2024 | CRL

Charles River Laboratories long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Charles River Laboratories long term debt for the quarter ending September 30, 2024 was $2.327B, a 7.46% decline year-over-year.
  • Charles River Laboratories long term debt for 2023 was $2.647B, a 2.23% decline from 2022.
  • Charles River Laboratories long term debt for 2022 was $2.708B, a 1.65% increase from 2021.
  • Charles River Laboratories long term debt for 2021 was $2.664B, a 38.04% increase from 2020.
Charles River Laboratories Annual Long Term Debt
(Millions of US $)
2023 $2,647
2022 $2,708
2021 $2,664
2020 $1,930
2019 $1,850
2018 $1,637
2017 $1,114
2016 $1,208
2015 $846
2014 $741
2013 $642
2012 $527
2011 $703
2010 $670
2009 $457
Charles River Laboratories Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $2,327
2024-06-30 $2,409
2024-03-31 $2,660
2023-12-31 $2,647
2023-09-30 $2,514
2023-06-30 $2,678
2023-03-31 $2,744
2022-12-31 $2,708
2022-09-30 $2,937
2022-06-30 $2,997
2022-03-31 $2,676
2021-12-31 $2,664
2021-09-30 $2,893
2021-06-30 $2,727
2021-03-31 $2,202
2020-12-31 $1,930
2020-09-30 $1,968
2020-06-30 $2,207
2020-03-31 $2,327
2019-12-31 $1,850
2019-09-30 $1,883
2019-06-30 $2,040
2019-03-31 $1,541
2018-12-31 $1,637
2018-09-30 $1,653
2018-06-30 $1,796
2018-03-31 $1,130
2017-12-31 $1,114
2017-09-30 $1,156
2017-06-30 $1,116
2017-03-31 $1,170
2016-12-31 $1,208
2016-09-30 $1,233
2016-06-30 $1,331
2016-03-31 $840
2015-12-31 $846
2015-09-30 $836
2015-06-30 $755
2015-03-31 $755
2014-12-31 $741
2014-09-30 $755
2014-06-30 $782
2014-03-31 $614
2013-12-31 $642
2013-09-30 $624
2013-06-30 $620
2013-03-31 $518
2012-12-31 $527
2012-09-30 $543
2012-06-30 $551
2012-03-31 $675
2011-12-31 $703
2011-09-30 $720
2011-06-30 $731
2011-03-31 $761
2010-12-31 $670
2010-09-30 $701
2010-06-30 $409
2010-03-31 $438
2009-12-31 $457
2009-09-30 $464
2009-06-30 $486
2009-03-31 $474
Sector Industry Market Cap Revenue
Medical Medical Services $9.314B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00